Pfizer’s Enhanced Vaccine Can Be Reduced By 20 Times The Risk Of Severe Illness

According to data from a short-term study in Israel, the third vaccine dose of Pfizer-Biontech can significantly reduce the incidence of diseases in people aged 60 and over. / 00/1: 54 namngien domain Posted in New Zealand Medical Journal on September 15 indicated that the risk of SARS-COV-2 infection decreased by 11 times and the risk of severe illness decreased by 20 times in enhanced nasal people compared to people injecting 2 The third vaccine dose. The third vaccine significantly reduces the risk of SARS-COV-2 infection in people over 60 years old. Artwork: Deseret News Enhanced Injection Plan in the United States has encountered many opinions. The leading expert on the infectious disease Anthony Fauci, Director of the Rochelle Walensky Disease Control and Prevention Center and the right to Member of the Food and Drug Administration (FDA) Janet Woodcock has supported the third vaccine injection , provided that additional injections must be approved by management agencies and medical officials

. Meanwhile, the top two officials of FDA's vaccine announced plans to resign this year, a sign that skeptical is skeptical for strengthening injection plans.FDA and Pfizer on September 15 Daddies summarize before the 17/9 meeting of advisers. Accordingly, the PFIZER report shows that the effectiveness of the Covid-19 vaccine can decline over time and enhanced injections will help maintain the level of protection of the vaccine
The FDA report indicates that the current vaccine still has effective prevention and death due to Covid-19. Israeli research has been watching more than 1.1 million Israeli people over 60 years old, who have injected 2 Pfizer Vaccine Nose. Researchers at the Weizmann Academy of Science, Technological Institute of Technology in Israel, Israeli Ministry of Health, Tel Aviv University and other scientists compared the risk of infection and severe illness among enhanced nasal people And those who do not inject the Bloomberg, a key note are Israeli's research based on short-term monitoring. Israeli strengthened injection campaign began on July 30 and this study took place until August 31. The risk of infection and severe disease is considered after 12 days since the third vaccine vaccine injection./.ctv Mai Trang / VOV.vn (translation) under Bloomberg

. Dịch vụ: Thiết kế website, quảng cáo google, đăng ký website bộ công thương uy tín

Related news